A Review of Western and Traditional Chinese Medical Approaches to Managing Nonalcoholic Fatty Liver Disease

被引:12
作者
Hsu, Wei-Fan [1 ]
Sheen, Lee-Yan [2 ]
Lin, Hung-Jen [3 ]
Chang, Hen-Hong [3 ,4 ,5 ]
机构
[1] China Med Univ Hosp, Div Hepatogastroenterol, Dept Internal Med, Taichung, Taiwan
[2] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei, Taiwan
[3] China Med Univ, Sch Postbaccalaureate Chinese Med, Coll Chinese Med, Taichung, Taiwan
[4] China Med Univ Hosp, Dept Chinese Med, Taichung, Taiwan
[5] China Med Univ, Res Ctr Chinese Med & Acupuncture, Taichung, Taiwan
关键词
AMELIORATES HEPATIC STEATOSIS; ACTIVATED PROTEIN-KINASE; LIPID-ACCUMULATION; BLADDER-CANCER; SCORING SYSTEM; PPAR-ALPHA; FIBROSIS; STEATOHEPATITIS; PREVALENCE; VALIDATION;
D O I
10.1155/2016/6491420
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is a disease of attention because of increase in prevalence from 20% to 41%. The clinical and pathological conditions in patients with NAFLD range from steatosis alone to nonalcoholic steatohepatitis (NASH) with or without fibrosis to hepatic cancer. In the United States, NAFLD was the second-leading indication for liver transplant between 2004 and 2013. Although imaging studies such as magnetic resonance elastography and the use of diagnostic panels and scoring systems can provide a fairly accurate diagnosis of NAFLD, there are few treatment options for patients with mild to moderate disease other than lifestyle modification. Many of the currently used medical treatments have been shown to cause severe side effects and some have been shown to be associated with increased risk for certain types of cancer. In recent years, a number of traditional Chinese herbal treatments have been examined for their potential uses as treatment for NAFLD. In this review, we provide a general overview of NAFLD and a survey of Western pharmacologic drugs currently used to treat the disease as well as the results of recent studies on the effectiveness of traditional Chinese herbal remedies for managing nonalcoholic fatty liver disease.
引用
收藏
页数:12
相关论文
共 84 条
[51]   Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes [J].
Lewis, James D. ;
Habel, Laurel A. ;
Quesenberry, Charles P. ;
Strom, Brian L. ;
Peng, Tiffany ;
Hedderson, Monique M. ;
Ehrlich, Samantha F. ;
Mamtani, Ronac ;
Bilker, Warren ;
Vaughn, David J. ;
Nessel, Lisa ;
Van Den Eeden, Stephen K. ;
Ferrara, Assiamira .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (03) :265-277
[52]  
Li W.H., 2014, SCI WORLD J, V2014, P10, DOI DOI 10.1155/2014/304203
[53]  
Lin TJ, 2005, WORLD J GASTROENTERO, V11, P3905
[54]   Herbal medicines for fatty liver diseases [J].
Liu, Zhao Lan ;
Xie, Liang Zhen ;
Zhu, Jiang ;
Li, George Q. ;
Grant, Suzanne J. ;
Liu, Jian Ping .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (08)
[55]   Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial [J].
Neuschwander-Tetri, Brent A. ;
Loomba, Rohit ;
Sanyal, Arun J. ;
Lavine, Joel E. ;
Van Natta, Mark L. ;
Abdelmalek, Manal F. ;
Chalasani, Naga ;
Dasarathy, Srinivasan ;
Diehl, Anna Mae ;
Hameed, Bilal ;
Kowdley, Kris V. ;
McCullough, Arthur ;
Terrault, Norah ;
Clark, Jeanne M. ;
Tonascia, James ;
Brunt, Elizabeth M. ;
Kleiner, David E. ;
Doo, Edward .
LANCET, 2015, 385 (9972) :956-965
[56]   Semen Astragali Complanati: An ethnopharmacological, phytochemical and pharmacological review [J].
Ng, Yam-Fung ;
Tang, Philip Chiu-Tsun ;
Sham, Tung-Ting ;
Lam, Wing-Sum ;
Mok, Daniel Kam-Wah ;
Chan, Shun-Wan .
JOURNAL OF ETHNOPHARMACOLOGY, 2014, 155 (01) :39-53
[57]   A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver [J].
Pais, Raluca ;
Charlotte, Frederic ;
Fedchuk, Larissa ;
Bedossa, Pierre ;
Lebray, Pascal ;
Poynard, Thierry ;
Ratziu, Vlad .
JOURNAL OF HEPATOLOGY, 2013, 59 (03) :550-556
[58]   Quantifying hepatic shear modulus in vivo using acoustic radiation force [J].
Palmeri, M. L. ;
Wang, M. H. ;
Dahl, J. J. ;
Frinkley, K. D. ;
Nightingale, K. R. .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2008, 34 (04) :546-558
[59]   Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease [J].
Palmeri, Mark L. ;
Wang, Michael H. ;
Rouze, Ned C. ;
Abdelmalek, Manal F. ;
Guy, Cynthia D. ;
Moser, Barry ;
Diehl, Anna Mae ;
Nightingale, Kathryn R. .
JOURNAL OF HEPATOLOGY, 2011, 55 (03) :666-672
[60]   Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice [J].
Quan, Hai-Yan ;
Yuan, Hai-Dan ;
Jung, Mi Song ;
Ko, Sung Kwon ;
Park, Young Guk ;
Chung, Sung Hyun .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 29 (01) :73-80